Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome
Kiran Girdhar(Icahn School of Medicine at Mount Sinai), Schahram Akbarian(Allen Institute for Brain Science), Brent T. Harris, Bibi Kassim(Icahn School of Medicine at Mount Sinai), Yan Jiang(Guangdong University of Technology), Mads E. Hauberg(Aarhus University), Elizabeth Zharovsky(Icahn School of Medicine at Mount Sinai), Eugenio Mattei(University of Massachusetts Chan Medical School), Jennifer Wiseman(Allen Institute for Brain Science), Gabriel E. Hoffman(Icahn School of Medicine at Mount Sinai), Nancy Francoeur(Icahn School of Medicine at Mount Sinai), Solveig K. Sieberts(Sage Bionetworks), Laura Sloofman(Child Health and Development Institute), Barbara K. Lipska(University of Bari Aldo Moro), Pamela Sklar(Allen Institute for Brain Science), Mette A. Peters(Sage Bionetworks), Panos Roussos(Allen Institute for Brain Science), Zhiping Weng(UMass Memorial Health Care), Jessica Johnson(University of North Carolina at Chapel Hill), Marija Kundaković(Fordham University), Ying‐Chih Wang(Northwestern University), Hardik Shah(Icahn School of Medicine at Mount Sinai), David H. Kavanagh(Cardiff University), Royce Park(Allen Institute for Brain Science), Rivka Jacobov(Allen Institute for Brain Science), Leanne Brown(Icahn School of Medicine at Mount Sinai)
Cited by 157
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k